Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey $heff or Biohunter ...appreciate your thoughts on MACK which
came roaring back today and has a PDUFA coming up sooon
OXGN on the move towards Nov catalyst
La Jolla Pharmaceutical Company Director Kevin C. Tang Purchases 169,555 Shares (LJPC)
http://sleekmoney.com/la-jolla-pharmaceutical-company-director-kevin-c-tang-purchases-169555-shares-ljpc/27470/
Hey $heff any thoughts on OREX
Thanx $heff...I grabbed a nice position e.o.d. on ACRX.
Looking for a nice recovery as date approaches like PGNX did.
UPDATE Nice Hire...
Today at 11:29 PM
April 30, 2014:
Newly created V.P. Of Sales and Marketing position: NanoLogix announces that the Company has hired a Vice President of Sales and Marketing, a newly-created position geared to the increase and acceleration of sales of the company's Petri plates, BNP/BNF kits, and the upcoming N-Assay Multiwell Microplate assay. The new Vice President brings three decades of experience in management, sales, and marketing of Diagnostics and Pharmaceuticals for a number of companies, with a significant period employed as a Senior District Manager for Novartis Pharmaceuticals. NanoLogix staff looks forward to working with the Vice President to expand sales across our entire product line. The VP will be attending the American Society for Microbiology (ASM) Annual Meeting in Boston from May 17-20 with other NanoLogix personnel, staffing the NanoLogix booth in the Exhibition Hall at the Boston Convention and Exhibition Center.
This is the first position of its type within the company since its founding in 1989. The company was focused upon nonrevenue projects for the first two decades of its existence and in 2007 began a transition in Research and Development that led to the development of the (2007) BNC multi-channel technology, the (2008) BNP membrane culture-based petri kit, the (2010) BNF/NC filter ab/ag test, and the new (2013-14) N-Assay Multiwell Microplate ELISA-based test. The company also benefits from an exclusive license for a revolutionary (2011) FlatPack packaging technology that provides dramatically extended shelf life for all of NanoLogix culture based petri products. In addition, in late 2013 the company began the electron beam processing of the majority of its culture based products in order to provide their customers with the best products available in the most pristine condition possible. This e-beam step was taken after a lengthy investigation into long-term storage under a variety of conditions with a focus on our products long, unparalleled storage life across the industry.
thanx...getting pretty cheap here but then again so r others
$heff any thoughts on NKTR down .36 at 10.66
Navb earnings....here ya go
http://biz.yahoo.com/research/earncal/n/navb.html
ooops go to charts at the top then plug in navb.
shows short volume only
Looks to me like shorts r covering...
http://www.shortanalytics.com/getshortchart.php?tsymbol=navb
hey sts66 where do u get the 17million covered from??
Thanx $heff... any idea on their cash position???
LifeTech Capital out with an update on NAVB
http://lifetechcapital.com/ltc/wp-content/uploads/2013/03/Mid-Day-Note-03-13-13-NAVB.pdf
Burrill Insti Research: NAVB update. 4Q12 Results – Focus on Approval, Launch, and Partnerships - Market Outperform / Spec Risk, Target: $5
Ladenburg Thalmann update report - Head and Neck Cancer and Colorectal Studies To Expand Market Opportunity, Potentially As Early as 2014. Reiterate Buy Rating and $7.50 PT.
JMP Securities NAVB update - Lymphoseek Approval Remains Key Catalyst - Market Outperform $6.00 Target
NAVB Lifetech Captital update
http://lifetechcapital.com/ltc/2013/03/navidea-navb-note-03-07-12/
RPTP close above 200ma with volume
been expecting a bear raid for a long time thats why i've had bids
in from 2.40 and down for a while now. doubt that target gets us even close to that. NAVB CC on thursday should be interesting.
shorts getting nervous though.
Be awesome if JPM came out with something now after there recent purchase....
NAVB...same analyst 2 years ago before company name change...
Wonder what he's up to????????
http://www.investorvillage.com/groups.asp?mb=16085&mid=10576520&pt=msg
AVNR The Michael J. Fox Foundation Awards Grant To Support Avanir Pharmaceuticals' Clinical Study Of AVP-923 For Levodopa Induced Dyskinesia In Parkinson's Disease
http://finance.yahoo.com/news/michael-j-fox-foundation-awards-123000938.html
What r the chances NAVB recieves a class 1 response to the crl from the FDA?
Hey guys don't know if that poster was for real or not but he is correct that Sam is working for Teknoscan... as for the rest...
I wouldn't believe anything that comes out of Mr. H's mouth.
Just keeps getting better
http://www.nanologix.com/cms-assets/documents/36828-273962.20111001-medical-design.pdf
Another key is never hold them overnight. Just day trade them
Shorts still not covering as of Mar/31
http://www.nasdaq.com/aspxcontent/shortinterests.aspx?symbol=AVNR&selected=AVNR
Thanx
I know that but when do they post the Mar 31 numbers?
Anybody know the latest short interest on AVNR?
as of end of March
Wouldn't it be nice if the news hits today on mdmn/cdch
NPHC nice run from .07
EGZ.VN RTQ .53
Be nice if they issue new ones at shareholder meeting at current
pps or higher.
Well at least were starting to see some volume here again.
Long overdue!!!
Agreed! I have all the shares that I need so bring it on.
now .33